Drug Shortage Report for KIVEXA

Last updated on 2019-03-15
Report ID 74011
Drug Identification Number 02269341
Brand name KIVEXA
Common or Proper name abacavir (as abacavir sulfate) and lamivudine tablets
Company Name VIIV HEALTHCARE ULC
Active Ingredient(s) ABACAVIR LAMIVUDINE
Strength(s) 600MG 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30's
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-01-25
Estimated end date 2019-03-18
Actual end date 2019-03-14
Shortage status Resolved
Updated date 2019-03-14
Company comments
Health Canada comments
Company contact information 1-877-393-8448